Skip to content

Friday, April 19, 2024

Latest:

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma
Collaborating with the community for autism research
Virtual education programs train clinicians around the world
First step to untangle DNA: capture gyrase like a lasso ropes cattle
Protecting your voice at games and concerts

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

lobular breast cancer

A potentially more effective treatment for HER2 mutant metastatic breast cancer

June 23, 2022 Breast Cancer, cancer treatment, HER2 mutations, lobular breast cancer, Metastasis, neratinib, poziotinib, Research

A phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.

From the Labs Image of the Month:

From the Labs: Human retinal organoid.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951